July 28, 2026 
5 min read
For decades, Alzheimer’s disease research was dominated by a single hypothesis: that the disease was caused by the accumulation of amyloid plaques in the brain. Clear them, the thinking went, and you could stop the disease.
That hypothesis has proven to be far more complicated than initially hoped. Several high-profile drug trials targeting amyloid directly failed to produce the clinical outcomes researchers expected. And in the meantime, a parallel body of research has been building a different or more accurately, a more complete picture of what Alzheimer’s disease actually is.
Increasingly, the evidence points to the immune system as a central player in neurodegeneration. Not just in Alzheimer’s, but across the broader spectrum of conditions that steal cognition and independence from millions of people worldwide.
The Brain Has an Immune System and It Can Go Wrong
The brain was long thought to be what immunologists call “immune privileged”, a compartment isolated from the rest of the body’s immune activity. That understanding has been significantly revised.
The brain has its own resident immune cells, called microglia, that perform critical maintenance functions: pruning synapses, clearing cellular debris, and responding to infection or injury. Under normal conditions, this is essential and protective.
But under conditions of chronic stress, metabolic dysfunction, gut microbiome imbalance, sleep deprivation, or persistent viral and bacterial exposure, microglial activation can become dysregulated. Instead of a targeted, time-limited response, the brain enters a state of chronic low-grade neuroinflammation and that neuroinflammatory state appears to be a significant driver of neurodegenerative disease.
What the Research Shows About Alzheimer's and Inflammation
Multiple lines of evidence now connect chronic neuroinflammation to Alzheimer’s disease pathology. Elevated inflammatory markers are found in the cerebrospinal fluid and brain tissue of Alzheimer’s patients. Genetic risk factors for Alzheimer’s; most notably the APOE4 allele are associated with altered immune function, not just altered amyloid processing. And epidemiological studies consistently find that conditions associated with systemic inflammation, obesity, type 2 diabetes, cardiovascular disease, sleep disorders, are also risk factors for Alzheimer’s.
This does not mean amyloid is irrelevant. It may mean that the story is more complex: that inflammation and amyloid interact, amplify each other, and together produce the neurodegeneration that defines the disease. Some researchers now describe Alzheimer’s as a fundamentally inflammatory condition, with amyloid as one of several downstream consequences.
Immunodegenerative Disease: A Framework for Understanding
The Renewed Recovery Foundation works at the intersection of neurodegenerative and immunodegenerative disease and that intersection is not accidental. The conditions that accelerate brain aging and cognitive decline are very often conditions of immune dysfunction.
Chronic inflammation, autoimmune conditions, mitochondrial impairment, and metabolic dysregulation all converge on common pathways that drive tissue damage in the brain. Understanding this convergence is not just scientifically interesting it is practically important, because it suggests that interventions targeting immune health and metabolic function may have meaningful protective effects on neurological health.
What You Can Do: The Modifiable Risk Factors
The relationship between inflammation and neurodegeneration is not a counsel of despair. Many of the drivers of chronic neuroinflammation are modifiable and the lifestyle interventions that reduce systemic inflammation are among the most robustly evidence-supported strategies for preserving cognitive health.
Sleep is foundational. The brain’s glymphatic system which clears metabolic waste including amyloid operates primarily during deep sleep. Chronic sleep deprivation impairs this clearance process directly.
Diet matters significantly. Anti-inflammatory nutritional patterns characterized by high intake of omega-3 fatty acids, polyphenol-rich vegetables and fruits, fermented foods that support microbiome health, and low intake of ultra-processed foods and refined sugars — are associated with reduced inflammatory markers and better cognitive outcomes in longitudinal studies.
Exercise is one of the most powerful anti-inflammatory interventions available. Regular physical activity reduces systemic inflammatory markers, supports mitochondrial health, promotes neuroplasticity, and is consistently associated with reduced dementia risk across large population studies.
Stress management, social connection, and purpose are not soft addons; they are biological inputs. Chronic psychosocial stress activates the same inflammatory pathways that drive neurodegeneration. Social isolation is now recognized as a significant risk factor for cognitive decline.
The Research Frontier
The emerging science of neuroimmunology is one of the most exciting frontiers in medicine today. Researchers are investigating the role of specific immune pathways in Alzheimer’s and related conditions, the contribution of the gut-brain axis to neuroinflammatory disease, and the potential for immune-modulating interventions-nutritional, pharmaceutical, and lifestyle-based to slow or prevent neurodegeneration.
The Renewed Recovery Foundation is committed to supporting and translating this research, connecting the frontier of science with the communities that need it most, including the underserved populations who carry disproportionate burdens of both inflammatory disease and cognitive decline.
Join the Mission
Alzheimer’s is not inevitable. It is not simply genetic fate. It is a disease with roots in biology that we are increasingly able to understand, address, and in some cases prevent. The immune connection is not a footnote to that story it may be the central chapter.
Renewed Recovery Foundation is a registered 501(c)(3) nonprofit organization. Contributions are tax-deductible to the extent allowed by law.
